Ebola Crisis Deepens in DR Congo as Unpaid Health Workers Strike, WHO Warns of Hidden Toll

The Democratic Republic of Congo is grappling with a rapidly worsening Ebola crisis, now reporting over 2,000 confirmed cases and more than 700 deaths, making it the fastest-growing and third-largest Ebola outbreak ever recorded. This dire situation is compounded by frontline health workers in Ituri Province threatening, or already staging, strikes over months of unpaid salaries and allowances, severely disrupting containment efforts. The World Health Organization (WHO) has issued an urgent warning that the true scale of infections could be two to four times higher than official figures, with a vast majority of new cases emerging from 'unknown chains of transmission'. This deadly wave, caused by the aggressive Bundibugyo strain for which no approved vaccine exists, has spread to five provinces in the DRC, with worrying signs of cross-border transmission to Uganda and even an imported case in France. The humanitarian crisis is escalating amidst decades of conflict and a fragile healthcare system, leaving medical teams battling the highly infectious virus under perilous conditions. Efforts to find a breakthrough are underway, with clinical trial for potential treatments like MBP-134 and remdesivir now enrolling patients, and a trial for post-exposure prophylaxis (PEP) using obeldesivir recently launched in Ituri to protect those exposed to the virus. Authorities are racing against time, with Health Minister Samuel Roger Kamba Mulamba acknowledging payment delays and promising solutions, even as the WHO emergencies director, Chikwe Ihekweazu, stresses that the world must not become 'despondent' but rather enhance its collective response. The immediate future hinges on swiftly resolving the health worker payment dispute, ramping up effective contact tracing, and accelerating the development and deployment of specific Bundibugyo-targeted vaccines, with several candidates from entities like Oxford University and the Serum Institute of India now in accelerated development or early-stage trials. Without these critical interventions, the epidemic's trajectory threatens wider regional destabilization and a prolonged health disaster.